Spire Wealth Management Tg Therapeutics, Inc. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$7.81 - $20.45 $624 - $1,636	-80 Closed	0 $0
Q4 2021 Jan 14, 2022	SELL	$15.2 - $35.51 $9,986 - $23,330	-657 Reduced 89.15%	80 $2,000
Q2 2021 Jul 26, 2021	BUY	$32.5 - $48.96 $9,685 - $14,590	298 Added 67.88%	737 $29,000
Q1 2021 May 21, 2021	BUY	$41.61 - $54.3 $18,266 - $23,837	439 New	439 $36,000

336

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.